BRAF-V600 Mutations Have No Prognostic Impact in Stage IV Melanoma Patients Treated with Monochemotherapy

BACKGROUND: The impact of BRAF tumor mutations on the natural course of disease of melanoma patients is controversial. PATIENTS AND METHODS: We analyzed the mutational status and overall survival of 215 patients receiving treatment with dacarbazine or temozolomide. All patients who started first-lin...

Full beskrivning

Sparad:
Bibliografiska uppgifter
Huvudupphovsmän: Meckbach, Diana, Keim, Ulrike, Richter, Sabina, Leiter, Ulrike, Eigentler, Thomas K., Bauer, Jürgen, Pflugfelder, Annette, Büttner, Petra, Garbe, Claus, Weide, Benjamin
Materialtyp: Artigo
Språk:Inglês
Publicerad: Public Library of Science 2014
Ämnen:
Research Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC3930670/
https://ncbi.nlm.nih.gov/pubmed/24586605
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0089218
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk